Vimab Group AB (FRA:NM4) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:NM4 Vimab Group AB FRA:NM4
51 GF Score
Price €0.27
GF Value €0.51
! 5 Warning Signs
View Full Analysis

What is Vimab Group AB FFO per Share?

FFO per Share only applies to REITs.

FRA:NM4
51GF Score
Vimab Group AB FRA:NM4
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Vimab Group AB (FRA:NM4) Overvalued in 2026?

Based on GuruFocus' analysis, Vimab Group AB stock appears to be undervalued. The current stock price of €0.27 is trading 46.5% below its estimated GF Value™ of €0.51.

Key valuation signals for FRA:NM4:

  • FFO per Share:
  • GF Value™: €0.51 vs. price of €0.27 (46.5% below fair value)
  • GF Score™: 51/100 with 5 warning signs

No single metric tells the full story. See the FRA:NM4 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vimab Group AB Business Description

Other Exchanges VIMAB:Sweden
Address Malmskillnadsgatan 40A, Stockholm, SWE, 111 57
Vimab Group AB is a Nordic company helping companies with transformation and improvement initiatives. It offers services including Interim management, Executive search.
51GF Score

Get the complete analysis for FRA:NM4

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.27
Price
€0.51
GF Value